SCHEMBL7422984

SCHEMBL7422984

COC(=O)c1ccc2c3c(n(Cc4ccccc4Cl)c2c1)C(=O)CCC3

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.47
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 3/20 0.47
MAPK1 P28482 3/20 0.47
HTT P42858 1/20 0.47
HPGD P15428 3/20 0.44
TSHR P16473 1/20 0.44
MAPT P10636 6/20 0.43
TP53 P04637 4/20 0.43
LMNA P02545 2/20 0.42
FABP4 P15090 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CREBBP Q92793 1/20 0.41
POLB P06746 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
PLA2G2A P14555 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7470778 0.94 DPP4 (0.46) DPP4KDM4EALDH1A1MAPK1HPGD
SCHEMBL7371677 0.89 ALDH1A1 (0.45) DPP4KDM4EALDH1A1HSD17B10MAPK1
SCHEMBL7416251 0.88 ALDH1A1 (0.54) DPP4KDM4EALDH1A1HSD17B10MAPK1
SCHEMBL7423051 0.87 DPP4 (0.45) DPP4KDM4EALDH1A1HSD17B10MAPK1
SCHEMBL7474547 0.86 HDAC1 (0.52) DPP4KDM4EALDH1A1MAPK1HPGD
SCHEMBL7420612 0.85 ALDH1A1 (0.44) DPP4KDM4EALDH1A1HSD17B10MAPK1
SCHEMBL7473427 0.82 DPP4 (0.46) DPP4KDM4EALDH1A1MAPK1HPGD
SCHEMBL7424979 0.82 FABP4 (0.51) DPP4KDM4EALDH1A1HSD17B10HPGD
SCHEMBL7467571 0.81 DPP4 (0.44) DPP4ALDH1A1TP53LMNAFABP4
SCHEMBL7474496 0.79 MEN1 (0.43) DPP4KDM4EALDH1A1HSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed